- Home
- KRNY vs EBS Comparison
KRNY vs EBS Comparison
Compare KRNY & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRNY
- EBS
- Stock Information
- Founded
- KRNY 1884
- EBS 1998
- Country
- KRNY United States
- EBS United States
- Employees
- KRNY 556
- EBS N/A
- Industry
- KRNY Savings Institutions
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- KRNY Finance
- EBS Health Care
- Exchange
- KRNY Nasdaq
- EBS Nasdaq
- Market Cap
- KRNY 410.4M
- EBS 393.9M
- IPO Year
- KRNY 2005
- EBS 2006
- Fundamental
- Price
- KRNY $6.34
- EBS $5.65
- Analyst Decision
- KRNY Buy
- EBS Strong Buy
- Analyst Count
- KRNY 2
- EBS 3
- Target Price
- KRNY $7.75
- EBS $14.33
- AVG Volume (30 Days)
- KRNY 328.5K
- EBS 1.1M
- Earning Date
- KRNY 04-24-2025
- EBS 05-07-2025
- Dividend Yield
- KRNY 6.91%
- EBS N/A
- EPS Growth
- KRNY N/A
- EBS N/A
- EPS
- KRNY N/A
- EBS N/A
- Revenue
- KRNY $148,766,000.00
- EBS $965,400,000.00
- Revenue This Year
- KRNY $17.60
- EBS N/A
- Revenue Next Year
- KRNY $22.31
- EBS $19.88
- P/E Ratio
- KRNY N/A
- EBS N/A
- Revenue Growth
- KRNY 4.47
- EBS N/A
- 52 Week Low
- KRNY $5.31
- EBS $4.02
- 52 Week High
- KRNY $8.59
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- KRNY 53.94
- EBS 65.88
- Support Level
- KRNY $6.23
- EBS $4.71
- Resistance Level
- KRNY $6.43
- EBS $5.70
- Average True Range (ATR)
- KRNY 0.18
- EBS 0.38
- MACD
- KRNY 0.03
- EBS 0.13
- Stochastic Oscillator
- KRNY 72.58
- EBS 85.77
About KRNY Kearny Financial Corp
Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.